We are pleased to invite you to the webinar titled ‘The Tale of Two Studies: Long-term treatment results from RA & PsA.' This interactive webinar aims to share with the rheumatology community the latest long-term efficacy and safety data for both RA and PsA.
- Provide information to rheumatologists on approved JAK inhibitors in the management of Rheumatoid Arthritis and IL 17 in the management of Psoriatic Arthritis.
- To share efficacy and safety related data.
FREE
Free